ALEMBICLTD vs KOLTEPATIL: Stock Comparison

ALEMBIC vs KOLTE PATIL DEV.Updated 11 Sept 26, 4:08 PM ISTNSE & company filings

KOLTE PATIL DEV. is the larger company by market capitalisation. ALEMBIC shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALEMBICLTD leads 11; KOLTEPATIL leads 2 of 13

Not a rating
These companies operate in different sectors (Services vs Realty). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALEMBICLTDKOLTEPATIL

Valuation lens

What price are you paying?

Market CapContext only
₹2,696 Cr
₹3,881 Cr
P/E RatioALEMBICLTD has the lower reading
8.41x
31.15x
P/B RatioALEMBICLTD has the lower reading
1.1x
3.22x
EPSKOLTEPATIL has the higher reading
₹2.53
₹16.49
Book ValueContext only
₹95.22
₹135.84
Dividend YieldALEMBICLTD has the higher reading
2.29%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
KOLTEPATIL is the larger company
₹3,881 Cr vs ₹2,696 Cr
P/E Ratio
ALEMBICLTD has a lower P/E
8.41x vs 31.15x
P/B Ratio
ALEMBICLTD has a lower P/B
1.1x vs 3.22x
EPS
KOLTEPATIL has higher earnings per share
₹16.49 vs ₹2.53
Dividend Yield
ALEMBICLTD has a higher dividend yield
2.29% vs 0%
Revenue Growth (TTM YoY)
ALEMBICLTD has faster revenue growth
-0.4% vs -65.4%
EPS Growth (TTM YoY)
KOLTEPATIL has faster EPS growth
0% vs -2.2%
Qtr Sales Growth
ALEMBICLTD has stronger quarterly sales growth
5.35% vs 4.26%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALEMBICLTDKOLTEPATIL
SectorServicesRealty
IndustryDiversified Commercial ServicesResidential Commercial Projects

Price

MetricALEMBICLTDKOLTEPATIL
Live Price₹104.33₹436.85
Day Change-2.04%-3.17%
Volume6.99 L84,268
52-Week High₹117.72₹554.6
52-Week Low₹70.46₹292.25
Distance from 52W High-11.37%-21.23%

Valuation

MetricALEMBICLTDKOLTEPATIL
Market Cap₹2,696 Cr₹3,881 Cr
P/E Ratio8.41x31.15x
P/B Ratio1.1x3.22x
EPS₹2.53₹16.49
Book Value₹95.22₹135.84
Dividend Yield2.29%0%

Growth

MetricALEMBICLTDKOLTEPATIL
Revenue Growth (TTM YoY)-0.4%-65.4%
EPS Growth (TTM YoY)-2.2%0%
Qtr Sales Growth5.35%4.26%
Qtr Profit Growth341.94%-7.74%

Profitability & Leverage

MetricALEMBICLTDKOLTEPATIL
ROE15.16%-3.16%
ROCE9.28%-0.45%
Net Margin132.25%3.52%
Operating Margin64.01%-1.3%
Debt to Equity0.01x0.95x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALEMBICLTDKOLTEPATIL
Promoter Holding70.88%33.81%
FII Holding1.25%10.61% 0.65 pp
DII Holding0.05%3.3% 0.09 pp
Public Holding27.81% 0.01 pp12.28% 0.55 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALEMBIC and KOLTE PATIL DEV..

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.